Avinger Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
39,901.00
31,964.00
47,344.00
56,128.00
48,732.00
27,558
Depreciation, Depletion & Amortization
1,501.00
1,451.00
1,300.00
1,506.00
1,476.00
1,281
Other Funds
-
1,848.00
-
-
-
9,822
Funds from Operations
36,331.00
25,367.00
37,581.00
44,396.00
31,417.00
16,455
Changes in Working Capital
4,324.00
3,566.00
3,302.00
8,673.00
3,059.00
2,166
Net Operating Cash Flow
40,655.00
21,801.00
40,883.00
53,069.00
34,476.00
18,621
Capital Expenditures
496.00
117.00
577.00
971.00
45.00
Sale of Fixed Assets & Businesses
-
-
-
-
4.00
Net Investing Cash Flow
496.00
117.00
322.00
971.00
41.00
Issuance/Reduction of Debt, Net
32,657.00
23,838.00
1,477.00
9,689.00
25.00
Net Financing Cash Flow
32,755.00
22,013.00
71,948.00
47,077.00
3,810.00
Net Change in Cash
8,396.00
95.00
30,743.00
6,963.00
30,707.00
Free Cash Flow
41,151.00
21,918.00
41,460.00
54,040.00
34,521.00
Other Sources
-
-
255.00
-
-
Change in Capital Stock
98.00
23.00
70,471.00
37,388.00
3,835.00

About Avinger

View Profile
Address
400 Chesapeake Drive
Redwood City California 94063
United States
Employees -
Website http://www.avinger.com
Updated 07/08/2019
Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease, or PAD. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists.